Care for patients with rheumatic diseases during COVID‐19 pandemic: A position statement from APLAR

L. Tam, Yoshiya Tanaka, R. Handa, Chi-chen Chang, Y. Cheng, Nazrul Isalm, Mengtao Li, Jose Paulo Lorenzo, Yeong-Wook Song, Kazuhiko Yamamoto, Xiaofeng Zeng, S. Haq

International journal of rheumatic diseases, 2020

1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China 2The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan 3Apollo Indraprastha Hospitals, New Delhi, India 4Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 5Allergy, Arthritis & Rheumatism Clinic, Farrer Park Hospital, Singapore City, Singapore 6Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore 7Deptartment of Rheumatology, BSMMU, Dhaka, Bangladesh 8Department of Rheumatology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College Hospital, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, Beijing, China 9Makati Medical Center, Makati, Philippines 10Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea 11Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan 12BSM Medical University, Dhaka, Bangladesh

Cited by 10 publications.

Field of study: Medicine

10.1111/1756-185X.13863